Thorac Cardiovasc Surg 2008; 56(7): 426-428
DOI: 10.1055/s-2007-989493
Short Communications

© Georg Thieme Verlag KG Stuttgart · New York

Intramural Hematoma of a Cryopreserved Aortic Homograft

L. Botta1 , G. Kloppenburg2 , A. Yilmaz2
  • 1Cardiac Surgery, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
  • 2Cardiothoracic Surgery, St. Antonius Ziekenhuis, Nieuwegein, Netherlands
Weitere Informationen

Publikationsverlauf

Received October 13, 2007

Publikationsdatum:
22. September 2008 (online)

Preview

Introduction

Infective endocarditis involving native valves (NVE) is associated with a lower in-hospital mortality and better prognosis than prosthetic valve endocarditis (PVE) [1]. PVE is a life-threatening surgical complication which can be treated with cryopreserved homografts (CH) since they have shown a good resistance to early re-infection combined with an acceptable long-term durability. Nevertheless the homograft itself can be susceptible to various diseases [2], [3]. In this paper we describe the incidental, intraoperative finding and subsequent treatment of an extensive intramural hematoma (IH) of a cryopreserved homograft already affected by severe post-infective aortic regurgitation. Due to its rarity, there is no general consensus on how best to handle this complex and quite exceptional allograft disease.

References

Dr. MD Luca Botta

University of Bologna, S. Orsola-Malpighi Hospital
Cardiac Surgery

Via Massarenti 9

40138 Bologna

Italy

Telefon: + 39 05 16 36 33 61

Fax: + 39 0 51 34 59 90

eMail: allucbot@tiscali.it